NC
Nexthera Capital Portfolio holdings
AUM
$120M
1-Year Return
20.18%
This Quarter Return
+3.84%
1 Year Return
+20.18%
3 Year Return
+117.79%
5 Year Return
–
10 Year Return
–
AUM
$407M
AUM Growth
+$123M
(+43%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
29.08%
Top 10 Holdings %
Top 10 Hldgs %
51.73%
Holding
58
New
21
Increased
11
Reduced
4
Closed
15
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$21.7M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$19M |
| 3 |
Corcept Therapeutics
CORT
|
$17.2M |
| 4 |
AstraZeneca
AZN
|
$16.9M |
| 5 |
Pacira BioSciences
PCRX
|
$14.9M |
Top Sells
| 1 |
Merck
MRK
|
$19.5M |
| 2 |
ABLX
Ablynx NV American Depositary Shares
ABLX
|
$15.9M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$11M |
| 4 |
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
|
$9.16M |
| 5 |
Viatris
VTRS
|
$8.62M |
Sector Composition
| 1 | Healthcare | 93.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
51
DELISTED
TESARO, Inc.
TSRO
| – | – |
0
| – | – |
|
|
ABLX
52
DELISTED
Ablynx NV American Depositary Shares
ABLX
| – | – |
-637,884
| Closed | -$15.9M |
|
|
SCMP
53
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| – | – |
-510,486
| Closed | -$9.16M |
|
|
54
Alnylam Pharmaceuticals
ALNY
$59.2B
| – | – |
-86,293
| Closed | -$11M |
|
55
ANI Pharmaceuticals
ANIP
$2.07B
| – | – |
-41,905
| Closed | -$2.7M |
|
56
Atara Biotherapeutics
ATRA
$90.7M
| – | – |
-11,466
| Closed | -$5.19M |
|
|
AVDL
57
Avadel Pharmaceuticals
AVDL
$1.53B
| – | – |
-505,921
| Closed | -$4.15M |
|
58
CytomX Therapeutics
CTMX
$376M
| – | – |
-179,870
| Closed | -$3.8M |
|